kynostatin 272 has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiso, Y | 1 |
| Fukasawa, T; Hayashi, H; Humphrey, RW; Kohler, DR; Mitsuya, H; Nguyen, BY; Shay, LE; Shintani, M; Steinberg, SM; Ueno, T; Wyvill, KM; Yarchoan, R | 1 |
1 review(s) available for kynostatin 272 and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Animals; Antiviral Agents; Binding Sites; Drug Design; HIV Protease; HIV Protease Inhibitors; Humans; Molecular Sequence Data; Oligopeptides; Phenylbutyrates | 1996 |
1 trial(s) available for kynostatin 272 and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Dose-Response Relationship, Drug; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Oligopeptides; RNA, Viral | 1999 |